Huntington Potter
Concepts (347)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 39 | 2024 | 513 | 6.870 |
Why?
| Amyloid beta-Peptides | 22 | 2022 | 200 | 3.930 |
Why?
| Electroporation | 7 | 2018 | 33 | 2.870 |
Why?
| Transfection | 9 | 2018 | 888 | 2.520 |
Why?
| Cognition Disorders | 13 | 2012 | 529 | 2.210 |
Why?
| Amyloid beta-Protein Precursor | 14 | 2022 | 55 | 1.760 |
Why?
| Cognitive Dysfunction | 6 | 2020 | 301 | 1.600 |
Why?
| Down Syndrome | 7 | 2024 | 356 | 1.410 |
Why?
| tau Proteins | 4 | 2019 | 78 | 1.400 |
Why?
| Aneuploidy | 4 | 2017 | 88 | 1.340 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2023 | 143 | 1.310 |
Why?
| Neuropsychological Tests | 14 | 2020 | 1032 | 1.280 |
Why?
| Cognition | 11 | 2022 | 1024 | 1.260 |
Why?
| Chromosome Segregation | 3 | 2013 | 35 | 1.100 |
Why?
| Mice, Transgenic | 19 | 2018 | 2025 | 1.010 |
Why?
| Neurons | 6 | 2017 | 1345 | 0.990 |
Why?
| Apolipoprotein E4 | 3 | 2022 | 37 | 0.970 |
Why?
| West Nile Fever | 2 | 2023 | 51 | 0.930 |
Why?
| Apolipoproteins E | 7 | 2019 | 90 | 0.900 |
Why?
| Dementia | 6 | 2012 | 208 | 0.890 |
Why?
| Spindle Apparatus | 3 | 2013 | 86 | 0.880 |
Why?
| Immune System | 2 | 2022 | 181 | 0.860 |
Why?
| Exosomes | 2 | 2020 | 92 | 0.840 |
Why?
| Brain | 14 | 2024 | 2490 | 0.820 |
Why?
| Peptide Fragments | 6 | 2022 | 702 | 0.780 |
Why?
| Caffeine | 4 | 2012 | 61 | 0.770 |
Why?
| Ultracentrifugation | 1 | 2020 | 49 | 0.760 |
Why?
| Psychiatric Status Rating Scales | 5 | 2012 | 499 | 0.760 |
Why?
| Apathy | 1 | 2020 | 7 | 0.750 |
Why?
| Hippocampus | 7 | 2022 | 735 | 0.740 |
Why?
| Temporal Lobe | 6 | 2012 | 90 | 0.730 |
Why?
| Animals | 37 | 2023 | 33381 | 0.710 |
Why?
| Presenilin-1 | 6 | 2016 | 29 | 0.690 |
Why?
| Mice | 26 | 2023 | 15520 | 0.690 |
Why?
| Alzheimer Vaccines | 2 | 2008 | 2 | 0.660 |
Why?
| Disease Models, Animal | 15 | 2022 | 3730 | 0.660 |
Why?
| Frontotemporal Lobar Degeneration | 1 | 2017 | 9 | 0.640 |
Why?
| Central Nervous System Stimulants | 3 | 2009 | 142 | 0.620 |
Why?
| Nanoparticles | 1 | 2020 | 325 | 0.570 |
Why?
| Uniparental Disomy | 1 | 2016 | 7 | 0.560 |
Why?
| alpha 1-Antichymotrypsin | 2 | 2006 | 2 | 0.550 |
Why?
| Amyloid | 3 | 2021 | 87 | 0.550 |
Why?
| Islet Amyloid Polypeptide | 3 | 2021 | 47 | 0.550 |
Why?
| Trisomy | 1 | 2016 | 66 | 0.530 |
Why?
| Atrophy | 8 | 2011 | 164 | 0.520 |
Why?
| Astrocytes | 3 | 2022 | 177 | 0.520 |
Why?
| DNA | 3 | 2018 | 1388 | 0.510 |
Why?
| Pneumonia, Viral | 1 | 2020 | 348 | 0.510 |
Why?
| Coronavirus Infections | 1 | 2020 | 339 | 0.510 |
Why?
| Proteomics | 1 | 2020 | 876 | 0.500 |
Why?
| Receptors, Neurotransmitter | 1 | 2014 | 16 | 0.490 |
Why?
| Maze Learning | 7 | 2010 | 86 | 0.480 |
Why?
| Protoplasts | 5 | 2018 | 7 | 0.480 |
Why?
| Cells, Cultured | 11 | 2020 | 4077 | 0.470 |
Why?
| Nerve Growth Factors | 1 | 2014 | 74 | 0.470 |
Why?
| Gene Expression | 4 | 2020 | 1489 | 0.470 |
Why?
| Niemann-Pick Disease, Type C | 1 | 2013 | 2 | 0.460 |
Why?
| Mitosis | 2 | 2011 | 172 | 0.460 |
Why?
| Mutation | 6 | 2017 | 3457 | 0.460 |
Why?
| Humans | 51 | 2024 | 118974 | 0.440 |
Why?
| Aged | 21 | 2023 | 19657 | 0.410 |
Why?
| Cholesterol, LDL | 1 | 2013 | 316 | 0.400 |
Why?
| Molecular Motor Proteins | 1 | 2011 | 34 | 0.390 |
Why?
| Memory, Episodic | 2 | 2021 | 42 | 0.370 |
Why?
| White Matter | 2 | 2023 | 115 | 0.370 |
Why?
| Chromosomes, Mammalian | 1 | 2009 | 26 | 0.370 |
Why?
| Receptors, LDL | 1 | 2010 | 40 | 0.360 |
Why?
| Neuropharmacology | 1 | 2009 | 4 | 0.360 |
Why?
| Amyloidosis | 1 | 2010 | 40 | 0.360 |
Why?
| Apoptosis | 2 | 2017 | 2484 | 0.360 |
Why?
| Infusion Pumps, Implantable | 1 | 2009 | 20 | 0.360 |
Why?
| Disease Progression | 6 | 2012 | 2490 | 0.360 |
Why?
| Plants | 4 | 2018 | 209 | 0.350 |
Why?
| Atherosclerosis | 1 | 2013 | 345 | 0.350 |
Why?
| Checklist | 1 | 2010 | 81 | 0.340 |
Why?
| Multicenter Studies as Topic | 1 | 2010 | 253 | 0.340 |
Why?
| Catheters, Indwelling | 1 | 2009 | 81 | 0.340 |
Why?
| Magnetic Resonance Imaging | 9 | 2012 | 3174 | 0.330 |
Why?
| Aged, 80 and over | 13 | 2021 | 6561 | 0.330 |
Why?
| Encephalitis | 3 | 2020 | 129 | 0.300 |
Why?
| Plasma | 1 | 2009 | 224 | 0.290 |
Why?
| Activities of Daily Living | 1 | 2009 | 354 | 0.290 |
Why?
| Herpes Zoster | 2 | 2021 | 336 | 0.280 |
Why?
| Environment | 3 | 2007 | 346 | 0.280 |
Why?
| Mice, Inbred C57BL | 7 | 2017 | 4908 | 0.270 |
Why?
| Memory | 2 | 2020 | 230 | 0.270 |
Why?
| Genetic Loci | 2 | 2019 | 281 | 0.260 |
Why?
| Dendritic Cells | 1 | 2008 | 442 | 0.260 |
Why?
| Gliosis | 2 | 2023 | 35 | 0.250 |
Why?
| Intermediate Filament Proteins | 1 | 2004 | 69 | 0.250 |
Why?
| Reproducibility of Results | 5 | 2010 | 2874 | 0.250 |
Why?
| Genotype | 7 | 2017 | 1882 | 0.240 |
Why?
| Female | 24 | 2023 | 61565 | 0.240 |
Why?
| Algorithms | 2 | 2012 | 1541 | 0.230 |
Why?
| Muscles | 2 | 2017 | 333 | 0.230 |
Why?
| Analysis of Variance | 4 | 2010 | 1293 | 0.220 |
Why?
| Cytokines | 4 | 2022 | 1900 | 0.220 |
Why?
| Imipramine | 1 | 2022 | 15 | 0.220 |
Why?
| Cell Culture Techniques | 2 | 2018 | 356 | 0.220 |
Why?
| Predictive Value of Tests | 4 | 2011 | 1868 | 0.220 |
Why?
| Plant Cells | 3 | 2010 | 7 | 0.210 |
Why?
| Cell Line | 3 | 2017 | 2707 | 0.210 |
Why?
| Genetic Predisposition to Disease | 5 | 2019 | 2275 | 0.210 |
Why?
| Polymerization | 1 | 2022 | 129 | 0.200 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2022 | 139 | 0.200 |
Why?
| Catalysis | 1 | 2022 | 295 | 0.200 |
Why?
| Arthritis, Rheumatoid | 1 | 2010 | 989 | 0.200 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 827 | 0.200 |
Why?
| Interneurons | 1 | 2022 | 103 | 0.200 |
Why?
| Cerebral Cortex | 1 | 2004 | 416 | 0.200 |
Why?
| Arteritis | 1 | 2021 | 27 | 0.200 |
Why?
| Healthy Aging | 1 | 2021 | 18 | 0.200 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2021 | 87 | 0.190 |
Why?
| Chemical Precipitation | 1 | 2020 | 38 | 0.190 |
Why?
| Protein Aggregation, Pathological | 1 | 2020 | 17 | 0.190 |
Why?
| Male | 20 | 2021 | 57801 | 0.190 |
Why?
| Varicella Zoster Virus Infection | 1 | 2020 | 21 | 0.180 |
Why?
| Skin | 2 | 2017 | 657 | 0.180 |
Why?
| Microglia | 2 | 2023 | 221 | 0.180 |
Why?
| Plaque, Amyloid | 3 | 2011 | 18 | 0.180 |
Why?
| Homozygote | 2 | 2017 | 190 | 0.180 |
Why?
| Early Diagnosis | 2 | 2011 | 230 | 0.180 |
Why?
| Neurites | 2 | 2023 | 45 | 0.180 |
Why?
| Case-Control Studies | 6 | 2020 | 3171 | 0.180 |
Why?
| Herpesvirus 3, Human | 2 | 2021 | 389 | 0.180 |
Why?
| Gene Dosage | 2 | 2017 | 136 | 0.180 |
Why?
| Epitope Mapping | 2 | 2008 | 49 | 0.160 |
Why?
| Immunity | 1 | 2019 | 129 | 0.160 |
Why?
| Brain Mapping | 2 | 2012 | 532 | 0.160 |
Why?
| Gene Knock-In Techniques | 1 | 2018 | 47 | 0.160 |
Why?
| Thiones | 2 | 2016 | 14 | 0.160 |
Why?
| Gene Knockout Techniques | 1 | 2018 | 105 | 0.150 |
Why?
| Phospholipase C gamma | 1 | 2017 | 25 | 0.150 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2009 | 83 | 0.150 |
Why?
| Blotting, Western | 3 | 2011 | 1194 | 0.150 |
Why?
| Calcium | 2 | 2014 | 1169 | 0.150 |
Why?
| Phosphodiesterase Inhibitors | 2 | 2009 | 86 | 0.150 |
Why?
| Heterozygote | 1 | 2017 | 262 | 0.150 |
Why?
| Betacoronavirus | 1 | 2020 | 254 | 0.150 |
Why?
| Attention | 1 | 2020 | 408 | 0.150 |
Why?
| Transgenes | 1 | 2017 | 174 | 0.140 |
Why?
| Receptors, Immunologic | 1 | 2017 | 209 | 0.140 |
Why?
| Lithium Chloride | 1 | 2016 | 13 | 0.140 |
Why?
| Long-Term Potentiation | 2 | 2016 | 148 | 0.140 |
Why?
| Mammals | 2 | 2011 | 253 | 0.140 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2016 | 33 | 0.140 |
Why?
| Neuroimaging | 2 | 2023 | 256 | 0.140 |
Why?
| Dendritic Spines | 1 | 2016 | 52 | 0.140 |
Why?
| Executive Function | 1 | 2020 | 391 | 0.140 |
Why?
| Mosaicism | 1 | 2016 | 62 | 0.130 |
Why?
| Functional Laterality | 3 | 2012 | 208 | 0.130 |
Why?
| Mice, Inbred BALB C | 2 | 2008 | 1206 | 0.130 |
Why?
| Lipids | 1 | 2019 | 607 | 0.130 |
Why?
| Membrane Glycoproteins | 1 | 2017 | 446 | 0.130 |
Why?
| Pyrimidines | 2 | 2016 | 382 | 0.120 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 394 | 0.120 |
Why?
| Middle Aged | 10 | 2021 | 27617 | 0.120 |
Why?
| PC12 Cells | 1 | 2014 | 40 | 0.120 |
Why?
| Genome-Wide Association Study | 3 | 2019 | 1323 | 0.120 |
Why?
| Recombinant Proteins | 2 | 2023 | 1308 | 0.120 |
Why?
| Nerve Growth Factor | 1 | 2014 | 29 | 0.120 |
Why?
| Polymorphism, Single Nucleotide | 3 | 2017 | 2062 | 0.120 |
Why?
| Anxiety | 1 | 2020 | 845 | 0.120 |
Why?
| Amnesia | 2 | 2012 | 46 | 0.120 |
Why?
| Risk Factors | 6 | 2014 | 9000 | 0.120 |
Why?
| Membrane Fluidity | 1 | 2013 | 10 | 0.120 |
Why?
| Immunohistochemistry | 4 | 2011 | 1691 | 0.110 |
Why?
| Pancreatitis, Alcoholic | 1 | 2012 | 2 | 0.110 |
Why?
| Trypsinogen | 1 | 2012 | 9 | 0.110 |
Why?
| Cell Cycle | 1 | 2016 | 550 | 0.110 |
Why?
| Trypsin | 1 | 2012 | 72 | 0.110 |
Why?
| Claudins | 1 | 2012 | 24 | 0.110 |
Why?
| Memory Disorders | 2 | 2012 | 168 | 0.110 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 191 | 0.110 |
Why?
| Glutamic Acid | 1 | 2014 | 224 | 0.110 |
Why?
| Enzyme Inhibitors | 1 | 2016 | 827 | 0.110 |
Why?
| Neuroglia | 1 | 2013 | 157 | 0.110 |
Why?
| Brain Chemistry | 1 | 2012 | 119 | 0.100 |
Why?
| Neuronal Plasticity | 1 | 2014 | 219 | 0.100 |
Why?
| Longitudinal Studies | 4 | 2012 | 2513 | 0.100 |
Why?
| Follow-Up Studies | 2 | 2011 | 4596 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1355 | 0.100 |
Why?
| Centrosome | 1 | 2011 | 59 | 0.100 |
Why?
| Parkinsonian Disorders | 1 | 2011 | 29 | 0.100 |
Why?
| Immunity, Innate | 1 | 2017 | 745 | 0.100 |
Why?
| Entorhinal Cortex | 1 | 2011 | 10 | 0.100 |
Why?
| Age Factors | 2 | 2009 | 2995 | 0.100 |
Why?
| Mice, Knockout | 2 | 2010 | 2680 | 0.100 |
Why?
| Myocytes, Smooth Muscle | 1 | 2013 | 236 | 0.100 |
Why?
| Inflammation | 1 | 2022 | 2566 | 0.100 |
Why?
| Molecular Targeted Therapy | 1 | 2014 | 356 | 0.100 |
Why?
| Xenopus | 1 | 2011 | 104 | 0.100 |
Why?
| Biomarkers | 2 | 2021 | 3588 | 0.100 |
Why?
| Vaccines, DNA | 1 | 2010 | 32 | 0.100 |
Why?
| Oocytes | 1 | 2011 | 190 | 0.090 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2010 | 18 | 0.090 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 70 | 0.090 |
Why?
| Florida | 1 | 2009 | 73 | 0.090 |
Why?
| Serine Proteinase Inhibitors | 1 | 2009 | 35 | 0.090 |
Why?
| Homeostasis | 1 | 2013 | 594 | 0.090 |
Why?
| Observer Variation | 1 | 2010 | 309 | 0.090 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2009 | 46 | 0.090 |
Why?
| Microdialysis | 1 | 2009 | 65 | 0.090 |
Why?
| Tubulin | 1 | 2010 | 122 | 0.080 |
Why?
| Theophylline | 1 | 2009 | 60 | 0.080 |
Why?
| Geriatric Assessment | 1 | 2010 | 185 | 0.080 |
Why?
| Genetic Therapy | 1 | 2010 | 267 | 0.080 |
Why?
| Cell Line, Transformed | 1 | 2009 | 136 | 0.080 |
Why?
| Drug Synergism | 1 | 2009 | 339 | 0.080 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 310 | 0.080 |
Why?
| Psychomotor Performance | 2 | 2009 | 290 | 0.080 |
Why?
| Ethanol | 1 | 2013 | 575 | 0.080 |
Why?
| Fibroblasts | 1 | 2013 | 842 | 0.080 |
Why?
| Antibody Specificity | 1 | 2008 | 184 | 0.080 |
Why?
| Drug Interactions | 1 | 2009 | 352 | 0.080 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 140 | 0.080 |
Why?
| Cross Reactions | 1 | 2008 | 116 | 0.080 |
Why?
| Time Factors | 2 | 2009 | 6412 | 0.080 |
Why?
| Cell Cycle Proteins | 1 | 2011 | 565 | 0.080 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 290 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 982 | 0.080 |
Why?
| Genetic Variation | 1 | 2012 | 926 | 0.080 |
Why?
| Blood | 1 | 2007 | 100 | 0.080 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2007 | 62 | 0.070 |
Why?
| Exploratory Behavior | 1 | 2007 | 90 | 0.070 |
Why?
| Retrospective Studies | 2 | 2022 | 12978 | 0.070 |
Why?
| Aging | 2 | 2009 | 1670 | 0.070 |
Why?
| t-Complex Genome Region | 1 | 2006 | 3 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 276 | 0.070 |
Why?
| Supranuclear Palsy, Progressive | 1 | 2006 | 6 | 0.070 |
Why?
| Bone Marrow | 1 | 2008 | 255 | 0.070 |
Why?
| Platelet-Derived Growth Factor | 1 | 2006 | 83 | 0.070 |
Why?
| Rolipram | 1 | 2006 | 3 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 736 | 0.070 |
Why?
| In Situ Nick-End Labeling | 1 | 2006 | 124 | 0.070 |
Why?
| Silver Staining | 1 | 2006 | 19 | 0.070 |
Why?
| Valine | 1 | 2006 | 77 | 0.070 |
Why?
| Phosphorylation | 2 | 2011 | 1633 | 0.070 |
Why?
| Up-Regulation | 1 | 2010 | 872 | 0.070 |
Why?
| Problem Solving | 1 | 2007 | 145 | 0.070 |
Why?
| Methionine | 1 | 2006 | 145 | 0.070 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 160 | 0.070 |
Why?
| Immunologic Memory | 1 | 2008 | 313 | 0.070 |
Why?
| Behavior, Animal | 2 | 2006 | 486 | 0.070 |
Why?
| Superoxide Dismutase | 1 | 2007 | 339 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2011 | 2674 | 0.070 |
Why?
| Microtubule-Associated Proteins | 1 | 2006 | 188 | 0.070 |
Why?
| Rats | 1 | 2014 | 5392 | 0.070 |
Why?
| Spinal Cord | 1 | 2007 | 367 | 0.060 |
Why?
| Lysine | 1 | 2006 | 248 | 0.060 |
Why?
| Spleen | 1 | 2006 | 510 | 0.060 |
Why?
| Benzothiazoles | 1 | 2004 | 37 | 0.060 |
Why?
| Flow Cytometry | 1 | 2008 | 1085 | 0.060 |
Why?
| Genetics, Behavioral | 1 | 2004 | 43 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1945 | 0.060 |
Why?
| Peptides | 1 | 2009 | 879 | 0.060 |
Why?
| Thiazoles | 1 | 2004 | 121 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 770 | 0.060 |
Why?
| Gene Frequency | 2 | 2017 | 513 | 0.060 |
Why?
| Memory, Short-Term | 1 | 2006 | 233 | 0.060 |
Why?
| Immunoglobulin G | 1 | 2008 | 788 | 0.060 |
Why?
| Indicators and Reagents | 1 | 2003 | 100 | 0.060 |
Why?
| Biological Specimen Banks | 1 | 2024 | 104 | 0.060 |
Why?
| Europe | 1 | 2024 | 356 | 0.060 |
Why?
| Diffusion Tensor Imaging | 1 | 2023 | 73 | 0.060 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 90 | 0.060 |
Why?
| West Nile virus | 1 | 2023 | 38 | 0.060 |
Why?
| RNA, Messenger | 1 | 2010 | 2657 | 0.050 |
Why?
| Nuclear Proteins | 1 | 2006 | 597 | 0.050 |
Why?
| Caspase 3 | 1 | 2023 | 243 | 0.050 |
Why?
| Prognosis | 1 | 2010 | 3443 | 0.050 |
Why?
| Pregnancy | 1 | 2014 | 5691 | 0.050 |
Why?
| Models, Biological | 1 | 2009 | 1715 | 0.050 |
Why?
| Viral Load | 1 | 2023 | 419 | 0.050 |
Why?
| DNA, Complementary | 1 | 2021 | 268 | 0.050 |
Why?
| T-Lymphocytes | 1 | 2008 | 1774 | 0.050 |
Why?
| Intracellular Space | 1 | 2020 | 69 | 0.050 |
Why?
| Extracellular Space | 1 | 2020 | 127 | 0.040 |
Why?
| Protein Aggregates | 1 | 2020 | 70 | 0.040 |
Why?
| Acyclovir | 1 | 2020 | 105 | 0.040 |
Why?
| Viral Envelope Proteins | 1 | 2020 | 80 | 0.040 |
Why?
| Child, Preschool | 1 | 2013 | 9491 | 0.040 |
Why?
| DNA, Viral | 1 | 2021 | 356 | 0.040 |
Why?
| Adult | 3 | 2020 | 31512 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 4552 | 0.040 |
Why?
| Surveys and Questionnaires | 1 | 2010 | 4708 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2022 | 495 | 0.040 |
Why?
| Young Adult | 1 | 2013 | 10793 | 0.040 |
Why?
| Image Processing, Computer-Assisted | 2 | 2012 | 709 | 0.040 |
Why?
| Protein Interaction Maps | 1 | 2017 | 36 | 0.040 |
Why?
| Haplotypes | 1 | 2019 | 473 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 300 | 0.040 |
Why?
| Linkage Disequilibrium | 1 | 2017 | 273 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 1 | 2017 | 372 | 0.040 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2445 | 0.040 |
Why?
| Genetic Testing | 1 | 2019 | 389 | 0.040 |
Why?
| Discriminant Analysis | 2 | 2007 | 41 | 0.040 |
Why?
| Exome | 1 | 2017 | 220 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2019 | 477 | 0.030 |
Why?
| Long-Term Synaptic Depression | 1 | 2016 | 51 | 0.030 |
Why?
| Cell Proliferation | 1 | 2023 | 2275 | 0.030 |
Why?
| Sweden | 1 | 2015 | 63 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 92 | 0.030 |
Why?
| Odds Ratio | 1 | 2017 | 996 | 0.030 |
Why?
| Antiviral Agents | 1 | 2020 | 654 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2016 | 1094 | 0.030 |
Why?
| Drug Discovery | 1 | 2014 | 124 | 0.030 |
Why?
| Pedigree | 1 | 2015 | 485 | 0.030 |
Why?
| Child | 1 | 2013 | 19129 | 0.030 |
Why?
| Congresses as Topic | 1 | 2014 | 204 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2017 | 2071 | 0.030 |
Why?
| Age of Onset | 1 | 2014 | 467 | 0.030 |
Why?
| Kinetics | 1 | 2016 | 1624 | 0.030 |
Why?
| Autopsy | 1 | 2012 | 89 | 0.030 |
Why?
| Stroke | 1 | 2021 | 1047 | 0.030 |
Why?
| Threonine | 1 | 2011 | 45 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2011 | 161 | 0.030 |
Why?
| Motor Activity | 2 | 2007 | 660 | 0.020 |
Why?
| ROC Curve | 1 | 2012 | 473 | 0.020 |
Why?
| Reference Values | 1 | 2012 | 774 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1597 | 0.020 |
Why?
| Statistics as Topic | 1 | 2011 | 307 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2014 | 969 | 0.020 |
Why?
| Linear Models | 1 | 2012 | 827 | 0.020 |
Why?
| Alleles | 1 | 2012 | 832 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2011 | 564 | 0.020 |
Why?
| Protein Processing, Post-Translational | 1 | 2011 | 408 | 0.020 |
Why?
| Superoxide Dismutase-1 | 1 | 2007 | 10 | 0.020 |
Why?
| Mice, Neurologic Mutants | 1 | 2007 | 19 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1781 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2011 | 1384 | 0.020 |
Why?
| Random Allocation | 1 | 2007 | 344 | 0.020 |
Why?
| Corticosterone | 1 | 2007 | 253 | 0.020 |
Why?
| RNA | 1 | 2012 | 833 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 2007 | 316 | 0.020 |
Why?
| Social Environment | 1 | 2007 | 294 | 0.020 |
Why?
| Motor Neurons | 1 | 2007 | 213 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2007 | 1166 | 0.020 |
Why?
| Synapses | 1 | 2007 | 344 | 0.020 |
Why?
| Avoidance Learning | 1 | 2004 | 64 | 0.020 |
Why?
| Space Perception | 1 | 2004 | 65 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2004 | 270 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 6471 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2004 | 336 | 0.010 |
Why?
| Regression Analysis | 1 | 2004 | 983 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 1798 | 0.010 |
Why?
| United States | 1 | 2015 | 12555 | 0.010 |
Why?
|
|
Potter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|